ADAM-10 is overexpressed in rheumatoid arthritis synovial tissue and mediates angiogenesis

Arthritis and Rheumatism

Volumn 65, Issue 1, 2013, Pages 98-108

  Isozaki, Takeo ^a   Rabquer, Bradley J ^a,b   Ruth, Jeffrey H ^a   Haines III, G Kenneth ^c   Koch, Alisa E ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ALBION COLLEGE   (United States)

^c YALE UNIVERSITY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM12 PROTEIN; ADAM8 PROTEIN; ADAM9 PROTEIN; CXCL16 CHEMOKINE; FRACTALKINE; MATRIGEL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL STIMULATION; CHEMOTAXIS; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM; WESTERN BLOTTING;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ARTHRITIS, RHEUMATOID; BLOTTING, WESTERN; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MEMBRANE PROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SYNOVIAL MEMBRANE;

EID: 84871754336     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37755     Document Type: Article

References (39)

1. Choy EH, Panayi GS,. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001; 344: 907-16.
2. Ritchlin C,. Fibroblast biology: effector signals released by the synovial fibroblast in arthritis. Arthritis Res 2000; 2: 356-60.
3. Buchan G, Barrett K, Turner M, Chantry D, Maini RN, Feldmann M,. Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1α. Clin Exp Immunol 1988; 73: 449-55.
4. Gabay C, Lamacchia C, Palmer G,. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 2010; 6: 232-41.
5. Toussirot E, Wendling D,. The use of TNF-α blocking agents in rheumatoid arthritis: an update. Expert Opin Pharmacother 2007; 8: 2089-107.
6. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, et al. Macrophage inflammatory protein-1α: a novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93: 921-8.
7. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-801.
8. Carmeliet P,. Angiogenesis in life, disease and medicine. Nature 2005; 438: 932-6.
9. Pruessmeyer J, Ludwig A,. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol 2009; 20: 164-74.
10. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, et al. ADAM10 regulates endothelial permeability and T-cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 2008; 102: 1192-201.
11. McCulloch DR, Akl P, Samaratunga H, Herington AC, Odorico DM,. Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res 2004; 10: 314-23.
12. Eichenauer DA, Simhadri VL, von Strandmann EP, Ludwig A, Matthews V, Reiners KS, et al. ADAM10 inhibition of human CD30 shedding increases specificity of targeted immunotherapy in vitro. Cancer Res 2007; 67: 332-8.
13. Weskamp G, Ford JW, Sturgill J, Martin S, Docherty AJ, Swendeman S, et al. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 2006; 7: 1293-8.
14. Hundhausen C, Misztela D, Berkhout TA, Broadway N, Saftig P, Reiss K, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003; 102: 1186-95.
15. Gough PJ, Garton KJ, Wille PT, Rychlewski M, Dempsey PJ, Raines EW,. A disintegrin and metalloproteinase 10-mediated cleavage and shedding regulates the cell surface expression of CXC chemokine ligand 16. J Immunol 2004; 172: 3678-85.
16. Komiya K, Enomoto H, Inoki I, Okazaki S, Fujita Y, Ikeda E, et al. Expression of ADAM15 in rheumatoid synovium: up-regulation by vascular endothelial growth factor and possible implications for angiogenesis. Arthritis Res Ther 2005; 7: R1158-73.
17. Ohta S, Harigai M, Tanaka M, Kawaguchi Y, Sugiura T, Takagi K, et al. Tumor necrosis factor-α (TNF-α) converting enzyme contributes to production of TNF-α in synovial tissues from patients with rheumatoid arthritis. J Rheumatol 2001; 28: 1756-63.
18. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
19. Ahmed S, Pakozdi A, Koch AE,. Regulation of interleukin-1β-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2006; 54: 2393-401.
20. Ditzel HJ,. The K/BxN mouse: a model of human inflammatory arthritis. Trends Mol Med 2004; 10: 40-5.
21. Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK III, Imhof BA, et al. Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum 2008; 58: 3020-9.
22. Rabquer BJ, Amin MA, Teegala N, Shaheen MK, Tsou PS, Ruth JH, et al. Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol 2010; 185: 1777-85.
23. Marotte H, Ruth JH, Campbell PL, Koch AE, Ahmed S,. Green tea extract inhibits chemokine production, but up-regulates chemokine receptor expression, in rheumatoid arthritis synovial fibroblasts and rat adjuvant-induced arthritis. Rheumatology (Oxford) 2010; 49: 467-79.
24. Ruth JH, Volin MV, Haines GK III, Woodruff DC, Katschke KJ Jr, Woods JM, et al. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 2001; 44: 1568-81.
25. Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE,. Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 2001; 159: 1521-30.
26. Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE,. Evidence of IL-18 as a novel angiogenic mediator. J Immunol 2001; 167: 1644-53.
27. Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE,. Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 2003; 93: 321-9.
28. Matsuo Y, Ochi N, Sawai H, Yasuda A, Takahashi H, Funahashi H, et al. CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 2009; 124: 853-61.
29. Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 2009; 113: 4799-809.
30. Gibb DR, Saleem SJ, Kang DJ, Subler MA, Conrad DH,. ADAM10 overexpression shifts lympho- and myelopoiesis by dysregulating site 2/site 3 cleavage products of Notch. J Immunol 2011; 186: 4244-52.
31. Glomski K, Monette S, Manova K, De Strooper B, Saftig P, Blobel CP,. Deletion of Adam10 in endothelial cells leads to defects in organ-specific vascular structures. Blood 2011; 118: 1163-74.
32. Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK III, et al. CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 2006; 54: 765-78.
33. Donners MM, Wolfs IM, Olieslagers S, Mohammadi-Motahhari Z, Tchaikovski V, Heeneman S, et al. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 2188-95.
34. Saito A, Sugawara A, Uruno A, Kudo M, Kagechika H, Sato Y, et al. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 2007; 148: 1412-23.
35. Firestein GS,. Evolving concepts of rheumatoid arthritis. Nature 2003; 423: 356-61.
36. Firestein GS,. Invasive fibroblast-like synoviocytes in rheumatoid arthritis: passive responders or transformed aggressors? [review]. Arthritis Rheum 1996; 39: 1781-90.
37. 3 specific. J Cell Sci 2006; 119: 490-9.
38. Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T,. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 2006; 203: 2703-14.
39. Rabquer BJ, Tsou PS, Hou Y, Thirunavukkarasu E, Haines GK III, Impens AJ, et al. Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis. Arthritis Res Ther 2011; 13: R18.